K Number
K122436
Device Name
COMPOSIX L/P MESH WITH ECHO PS POSITIONING SYSTEM VENTRALIGHT ST MESH WITH ECHO PS POSITIONING SYSTEM
Manufacturer
Date Cleared
2012-11-02

(84 days)

Product Code
Regulation Number
878.3300
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Ventralight™ ST Mesh is indicated for use in the reconstruction of soft tissue deficiencies, such as for the repair of hernias. The Echo PSTM Positioning System is intended to be used to facilitate the delivery of soft tissue prosthetics during laparoscopic hernia repair. Composix™ L/P Mesh is indicated for use in the reconstruction of soft tissue deficiencies, such as for the repair of hernias and chest wall defects. The Echo PSTM Positioning System is intended to be used to facilitate the delivery of soft tissue prosthetics during laparoscopic hernia repair.
Device Description
The proposed Ventralight™ ST Mesh with Echo PSTM Positioning System and Composix™ L/P Mesh with Echo PSTM Positioning System devices both comprise of a hernia repair mesh with a pre-attached mesh positioning system (mesh deployment balloon). The Ventralight™ ST Mesh is a low profile, sterile, single use device indicated for use in the reconstruction of soft tissue deficiencies, such as for the repair of hernias. This device is co-knitted using polypropylene (PP) and polyglycolic acid (PGA) fibers to result in a two-sided mesh with a PP surface and a PGA surface. The mesh is coated on the PGA surface with a bioresorbable, chemically modified sodium hyaluronate (HA), carboxymethylcellulose (CMC) and polyethylene glycol (PEG) based hydrogel that is resorbed from the site in less than 30 days. The Composix™ L/P Mesh is a low profile, nonabsorbable, sterile prosthesis indicated for use in the reconstruction of soft tissue deficiencies, such as for the repair of hernias and chest wall defects. It is constructed of one layer of large pore polypropylene mesh and one layer of expanded polytetrafluoroethylene (ePTFE) stitched together with PTFE monofilament. Each of the meshes described above will be sold pre-attached to the Echo PSTM Positioning System. The positioning system is composed of a nylon balloon that is preattached to the mesh via use of polycarbonate connectors, and is designed to help facilitate laparoscopic deployment, including unrolling, positioning, and placement of the prostheses. Both of the proposed devices will also include an Introducer Tool and inflation assembly accessory designed to aid the user in laparoscopic introduction and inflation of the mesh/positioning system assembly. The change described in this submission is a modification solely to the design of the Echo PSTM Positioning System which is sold pre-attached to both meshes and is identical in both products, with no change to either of the permanently implantable neemesh components or related accessories included with the device. The inflation tube component of the positioning system will be modified to include an anchor which will improve the connection between the tube and associated inflation assembly. This same inflation tube component of the positioning system is also being modified to include white markings which more clearly identify the cutting point of the tube to the user.
More Information

Not Found

No
The document describes a physical medical device (hernia mesh and positioning system) and its mechanical components. There is no mention of software, algorithms, data processing, or any terms related to AI or ML.

Yes
The device is indicated for the reconstruction of soft tissue deficiencies, such as for the repair of hernias and chest wall defects, which are therapeutic applications.

No

The device is a mesh and positioning system used for the reconstruction of soft tissue deficiencies, such as hernias and chest wall defects. Its purpose is therapeutic, not diagnostic.

No

The device description clearly states that the device comprises physical components including hernia repair mesh, a mesh positioning system (balloon), polycarbonate connectors, an introducer tool, and an inflation assembly accessory. These are all hardware components, not software.

Based on the provided text, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is for the "reconstruction of soft tissue deficiencies, such as for the repair of hernias and chest wall defects." This describes a surgical procedure to repair physical defects in the body.
  • Device Description: The device is a "hernia repair mesh with a pre-attached mesh positioning system (mesh deployment balloon)." It is a physical implant and a tool for its delivery.
  • Lack of Diagnostic Function: There is no mention of the device being used to examine specimens derived from the human body to provide information for the diagnosis, prevention, monitoring, treatment, or alleviation of disease.

IVD devices are used to perform tests on samples like blood, urine, or tissue to diagnose or monitor medical conditions. This device is a surgical implant and delivery system, not a diagnostic tool.

N/A

Intended Use / Indications for Use

  • The Ventralight™ ST Mesh is indicated for use in the reconstruction of soft tissue o deficiencies, such as for the repair of hernias. The Echo PS™ Positioning System is intended to be used to facilitate the delivery of soft tissue prosthetics during laparoscopic hernia repair.
  • Composix™ L/P Mesh is indicated for use in the reconstruction of soft tissue o deficiencies, such as for the repair of hernias and chest wall defects. The Echo PSTM Positioning System is intended to be used to facilitate the delivery of soft tissue prosthetics during laparoscopic hernia repair.

Product codes (comma separated list FDA assigned to the subject device)

FTL, OQL, GCJ

Device Description

The proposed Ventralight™ ST Mesh with Echo PSTM Positioning System and Composix™ L/P Mesh with Echo PSTM Positioning System devices both comprise of a hernia repair mesh with a pre-attached mesh positioning system (mesh deployment balloon). A brief description of the two (2) mesh components is as follows:

  • The Ventralight™ ST Mesh is a low profile, sterile, single use device indicated for 0 use in the reconstruction of soft tissue deficiencies, such as for the repair of hernias. This device is co-knitted using polypropylene (PP) and polyglycolic acid (PGA) fibers to result in a two-sided mesh with a PP surface and a PGA surface. The mesh is coated on the PGA surface with a bioresorbable, chemically modified sodium hyaluronate (HA), carboxymethylcellulose (CMC) and polyethylene glycol (PEG) based hydrogel that is resorbed from the site in less than 30 days.
  • The Composix™ L/P Mesh is a low profile, nonabsorbable, sterile prosthesis O indicated for use in the reconstruction of soft tissue deficiencies, such as for the repair of hernias and chest wall defects. It is constructed of one layer of large pore polypropylene mesh and one layer of expanded polytetrafluoroethylene (ePTFE) stitched together with PTFE monofilament.

Each of the meshes described above will be sold pre-attached to the Echo PSTM Positioning System. The positioning system is composed of a nylon balloon that is preattached to the mesh via use of polycarbonate connectors, and is designed to help facilitate laparoscopic deployment, including unrolling, positioning, and placement of the prostheses.

Both of the proposed devices will also include an Introducer Tool and inflation assembly accessory designed to aid the user in laparoscopic introduction and inflation of the mesh/positioning system assembly. Both of these accessories in the proposed device are identical to those cleared via K110820 and K102766.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Biocompatibility testing in accordance with ISO 10993-1 standards was conducted to assess the design modification on the proposed Ventralight™ ST Mesh with Echo PSTM Positioning System and Composix™ L/P Mesh with Echo PSTM Positioning System and the results indicate that the devices are biocompatible per these standards.
Bench testing results and in vivo simulated use experiments demonstrate that the proposed device design meets product specifications and intended uses.
All test results provided in this submission support the safety and effectiveness of the device for its intended use and demonstrate that the proposed device is substantially equivalent to its predicate devices.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K110820, K102766

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 878.3300 Surgical mesh.

(a)
Identification. Surgical mesh is a metallic or polymeric screen intended to be implanted to reinforce soft tissue or bone where weakness exists. Examples of surgical mesh are metallic and polymeric mesh for hernia repair, and acetabular and cement restrictor mesh used during orthopedic surgery.(b)
Classification. Class II.

0

K122436 Page 1/3

510(K) SUMMARY OF SAFETY AND EFFECTIVENESS

NOV 2 2012

This 510(k) Summary is provided per the requirements of section 807.92(c). The information listed below applies to and is identical for both devices being modified as part of thirobundly of submission.

Submitter Information:

Submitter's Name:Davol, Inc., Subsidiary of C. R. Bard, Inc.
Contact Person:Keti Sino
Regulatory Affairs Specialist
Address:100 Crossings Boulevard
Warwick, RI 02886
Telephone:(401) 825-8575
Fax:(401) 825-8765
Email:Keti.Sino@crbard.com

Device Name:

| Trade Names: | Ventralight™ ST Mesh with Echo PST™ Positioning System
Composix™ L/P Mesh with Echo PST™ Positioning System |
|--------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------|
| Common/Usual Names: | - Surgical Mesh

  • Endoscope & Accessories
  • Mesh Deployment Balloon |
    | Classification Names: | - Mesh, Surgical, Polymeric
  • Mesh Deployment Balloon
  • Laparoscope, General & Plastic Surgery |
    | Classification Codes:
    Subsequent Codes: | - Class II, § 878.3300, Product Code FTL
  • Class II, § 878.3300, Product Code OQL
  • Class II, § 876.1500, Product Code GCJ |

Predicate Device Names:

  • Ventralight™ ST Mesh with Echo PSTM Positioning System, K110820 (Davol Inc.), . FDA cleared on 04/01/2011
  • Composix™ L/P Mesh with Echo PS™ Positioning System, K102766 (Davol Inc.), . FDA cleared on 12/16/2010

Device Descriptions:

The proposed Ventralight™ ST Mesh with Echo PSTM Positioning System and Composix™ L/P Mesh with Echo PSTM Positioning System devices both comprise of a hernia repair mesh with a pre-attached mesh positioning system (mesh deployment balloon). A brief description of the two (2) mesh components is as follows:

PREMARKET NOTIFICATION FOR THE ECHO PSTM POSITIONING SYSTEM DEVICES

SECTION 8

1

K122436 Page 2/3

  • The Ventralight™ ST Mesh is a low profile, sterile, single use device indicated for 0 use in the reconstruction of soft tissue deficiencies, such as for the repair of hernias. This device is co-knitted using polypropylene (PP) and polyglycolic acid (PGA) fibers to result in a two-sided mesh with a PP surface and a PGA surface. The mesh is coated on the PGA surface with a bioresorbable, chemically modified sodium hyaluronate (HA), carboxymethylcellulose (CMC) and polyethylene glycol (PEG) based hydrogel that is resorbed from the site in less than 30 days.
  • The Composix™ L/P Mesh is a low profile, nonabsorbable, sterile prosthesis O indicated for use in the reconstruction of soft tissue deficiencies, such as for the repair of hernias and chest wall defects. It is constructed of one layer of large pore polypropylene mesh and one layer of expanded polytetrafluoroethylene (ePTFE) stitched together with PTFE monofilament.

Each of the meshes described above will be sold pre-attached to the Echo PSTM Positioning System. The positioning system is composed of a nylon balloon that is preattached to the mesh via use of polycarbonate connectors, and is designed to help facilitate laparoscopic deployment, including unrolling, positioning, and placement of the prostheses.

Both of the proposed devices will also include an Introducer Tool and inflation assembly accessory designed to aid the user in laparoscopic introduction and inflation of the mesh/positioning system assembly. Both of these accessories in the proposed device are identical to those cleared via K110820 and K102766.

Intended Uses:

  • The Ventralight™ ST Mesh is indicated for use in the reconstruction of soft tissue o deficiencies, such as for the repair of hernias. The Echo PS™ Positioning System is intended to be used to facilitate the delivery of soft tissue prosthetics during laparoscopic hernia repair.
  • Composix™ L/P Mesh is indicated for use in the reconstruction of soft tissue o deficiencies, such as for the repair of hernias and chest wall defects. The Echo PSTM Positioning System is intended to be used to facilitate the delivery of soft tissue prosthetics during laparoscopic hernia repair.

Summary of Similarities and Differences in Technological Characteristics, Performance and Intended Uses:

The Ventralight™ ST Mesh with Echo PSTM Positioning System has the same indication: reconstruction of soft tissues deficiencies such as the repair of hernias as well as to facilitate the delivery of soft tissue prosthetics during laparoscopic hernia repair. Further, the proposed product has the same physical attributes and performance characteristics as the predicate device.

The Composix™ L/P Mesh with Echo PS™ Positioning System has the same indication: reconstruction of soft tissues deficiencies such as the repair of hernias as well as to facilitate the delivery of soft tissue prosthetics during laparoscopic hernia repair. Fruther, the proposed product has the same physical attributes and performance characteristics as the predicate device.

PREMARKET NOTIFICATION FOR THE ECHO PSTM POSITIONING SYSTEM DEVICES

SECTION 8

2

K122436 page 3/3

The Introducer Tool and inflation assembly accessories to be included with either mesh configuration also maintain the same intended uses as their cleared predicates.

The change described in this submission is a modification solely to the design of the Echo PSTM Positioning System which is sold pre-attached to both meshes and is identical in both products, with no change to either of the permanently implantable neemesh components or related accessories included with the device.

The inflation tube component of the positioning system will be modified to include an anchor which will improve the connection between the tube and associated inflation assembly. This same inflation tube component of the positioning system is also being modified to include white markings which more clearly identify the cutting point of the tube to the user.

Performance Data:

Biocompatibility testing in accordance with ISO 10993-1 standards was conducted to assess the design modification on the proposed Ventralight™ ST Mesh with Echo PSTM Positioning System and Composix™ L/P Mesh with Echo PSTM Positioning System and the results indicate that the devices are biocompatible per these standards.

Bench testing results and in vivo simulated use experiments demonstrate that the proposed device design meets product specifications and intended uses.

All test results provided in this submission support the safety and effectiveness of the device for its intended use and demonstrate that the proposed device is substantially equivalent to its predicate devices.

PREMARKET NOTIFICATION FOR THE ECHO PSTM POSITIONING SYSTEM DEVICES

SECTION 8

3

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes coiled around it. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the caduceus symbol. The logo is black and white.

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-002

Letter Dated: November 2, 2012

C.R. Bard, Incorporated % Ms. Keti Sino Regulatory Affairs Specialist 100 Crossings Boulevard Warwick, Rhode Island 02886

Re: K122436

Trade Name: Ventralight" ST Mesh with Echo PS" Positioning System, Composix" L/P Mesh with Echo PS™ Positioning System Regulation Number: 21 CFR 878.3300. 21 CFR 878.1500 Regulation Name: Surgical Mesh Regulatory Class: II Product Code: FTL, OQL, GCJ Dated: October 05, 2012 Received: October 09, 2012

Dear Ms. Sino:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21

4

Page 2 - Ms. Keti Sino

CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely yours.

Mark N. Melkerson

Mark N. Melkerson Acting Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

5

INDICATION FOR USE STATEMENT

510(k) Number (if known):

Not known

Device Name:

Ventralight™ ST Mesh with Echo PSTM Positioning System

Ventralight™ ST Mesh is indicated for use in the reconstruction of soft tissue deficiencies, such as for the repair of hernias. The Echo PSTM Positioning System is intended to be used to facilitate the delivery of soft tissue prosthetics during laparoscopic hernia repair.

Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Dániel Kinefu MM

(Division Sign-Off) (Division of Surgical, Orthopedie, and Restorative Devices

510(k) Number K122436

23

6

INDICATION FOR USE STATEMENT

510(k) Number (if known):

Not known

Device Name:

Composix™ L/P Mesh with Echo PSTM Positioning System

Composix™ L/P Mesh is indicated for use in the reconstruction of soft tissue deficiencies, such as for the repair of hernias and chest wall defects. The Echo PSTM Positioning System is intended to be used to facilitate the delivery of soft tissue prosthetics during laparoscopic hernia repair.

Prescription Use X (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Daniel Knaebel MM
(Division Sign-Off)

Division of Surgical, Orthopedic, and Restorative Devices

510(k) Number K122436